塞力医疗: 信达证券股份有限公司关于塞力斯医疗科技集团股份有限公司变更募集资金专项账户的核查意见

Fundraising Overview - The company raised a total of RMB 625,959,956.79 from a non-public offering of A-shares in June 2018, with a net amount of RMB 607,608,016.80 after deducting issuance costs [1] - In 2020, the company issued convertible bonds, raising RMB 543,310,000.00, with a net amount of RMB 533,298,679.25 after related expenses [2] Fund Management - The company has established a special account storage system for the raised funds, with multiple accounts at various banks, including Bank of China and China Merchants Bank [2][4] - The company plans to change the special fundraising account to improve management efficiency and has signed a tripartite supervision agreement with the new bank [5] Board and Supervisory Approval - The board of directors unanimously approved the change of the special fundraising account, and the supervisory board also agreed, stating that the change would not affect the use of funds or harm shareholder interests [6][7] Regulatory Compliance - The company’s actions comply with relevant regulations, including the Shanghai Stock Exchange's rules on fundraising management and usage [6][7]